Logo image of TKNO

ALPHA TEKNOVA INC (TKNO) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:TKNO - US02080L1026 - Common Stock

4.3 USD
-0.12 (-2.82%)
Last: 11/21/2025, 8:02:40 PM
4.3 USD
0 (0%)
After Hours: 11/21/2025, 8:02:40 PM

TKNO Key Statistics, Chart & Performance

Key Statistics
Market Cap230.18M
Revenue(TTM)39.80M
Net Income(TTM)-18.22M
Shares53.53M
Float10.08M
52 Week High10.37
52 Week Low3.94
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.35
PEN/A
Fwd PEN/A
Earnings (Next)02-25 2026-02-25/amc
IPO2021-06-25
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


TKNO short term performance overview.The bars show the price performance of TKNO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20 -25

TKNO long term performance overview.The bars show the price performance of TKNO in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 50 100

The current stock price of TKNO is 4.3 USD. In the past month the price decreased by -24.3%. In the past year, price decreased by -41.34%.

ALPHA TEKNOVA INC / TKNO Daily stock chart

TKNO Latest News, Press Relases and Analysis

TKNO Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 26.23 221.84B
DHR DANAHER CORP 29.49 162.82B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 182.53 55.39B
A AGILENT TECHNOLOGIES INC 27.75 42.88B
IQV IQVIA HOLDINGS INC 19.34 38.23B
MTD METTLER-TOLEDO INTERNATIONAL 34.71 29.92B
WAT WATERS CORP 31.02 23.45B
WST WEST PHARMACEUTICAL SERVICES 38.34 19.49B
ILMN ILLUMINA INC 28.41 19.04B
MEDP MEDPACE HOLDINGS INC 41.39 16.67B
TEM TEMPUS AI INC N/A 12.21B
RVTY REVVITY INC 20.52 11.41B

About TKNO

Company Profile

TKNO logo image Alpha Teknova, Inc. engages in the manufacture of cell culture media and supplements. The company is headquartered in Hollister, California and currently employs 173 full-time employees. The company went IPO on 2021-06-25. The company offers two primary product categories, which include lab essentials and clinical solutions. The company also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The firm offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. The company supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.

Company Info

ALPHA TEKNOVA INC

2451 Bert Drive

Hollister CALIFORNIA US

CEO: Stephen Gunstream

Employees: 173

TKNO Company Website

TKNO Investor Relations

Phone: 18316371100

ALPHA TEKNOVA INC / TKNO FAQ

Can you describe the business of ALPHA TEKNOVA INC?

Alpha Teknova, Inc. engages in the manufacture of cell culture media and supplements. The company is headquartered in Hollister, California and currently employs 173 full-time employees. The company went IPO on 2021-06-25. The company offers two primary product categories, which include lab essentials and clinical solutions. The company also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The firm offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. The company supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.


Can you provide the latest stock price for ALPHA TEKNOVA INC?

The current stock price of TKNO is 4.3 USD. The price decreased by -2.82% in the last trading session.


Does TKNO stock pay dividends?

TKNO does not pay a dividend.


What is the ChartMill technical and fundamental rating of TKNO stock?

TKNO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


How is the valuation of ALPHA TEKNOVA INC (TKNO) based on its PE ratio?

ALPHA TEKNOVA INC (TKNO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.35).


Would investing in ALPHA TEKNOVA INC be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on TKNO.


What is ALPHA TEKNOVA INC worth?

ALPHA TEKNOVA INC (TKNO) has a market capitalization of 230.18M USD. This makes TKNO a Micro Cap stock.


TKNO Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

TKNO Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to TKNO. The financial health of TKNO is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TKNO Financial Highlights

Over the last trailing twelve months TKNO reported a non-GAAP Earnings per Share(EPS) of -0.35. The EPS increased by 49.28% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -16.93%
ROE -25.08%
Debt/Equity 0.18
Chartmill High Growth Momentum
EPS Q2Q%46.67%
Sales Q2Q%9.17%
EPS 1Y (TTM)49.28%
Revenue 1Y (TTM)9.5%

TKNO Forecast & Estimates

12 analysts have analysed TKNO and the average price target is 9.18 USD. This implies a price increase of 113.49% is expected in the next year compared to the current price of 4.3.

For the next year, analysts expect an EPS growth of 40.53% and a revenue growth 8.91% for TKNO


Analysts
Analysts81.67
Price Target9.18 (113.49%)
EPS Next Y40.53%
Revenue Next Year8.91%

TKNO Ownership

Ownership
Inst Owners14.78%
Ins Owners10.67%
Short Float %21.3%
Short Ratio7.9